👉Plasma and CSF Candidate Biomarkers of Neonatal #Encephalopathy Severity and Neurodevelopmental Outcomes

📌Plasma candidate biomarkers predicted #encephalopathy severity, #seizures, MRI abnormalities, and neurodevelopmental outcomes at 15-30 months.

🔗https://doi.org/10.1016/j.jpeds.2020.06.078

The pooled data suggest that #erythropoietin monotherapy may improve outcomes after neonatal #encephalopathy in LMICs where therapeutic hypothermia is not available

#neurology
doi.org/10.1038/s41372-021-01132-4

Neonatal #encephalopathy (NE) is a serious condition with devastating neurological outcomes that can impact oxygenation and ventilation

#neurology
doi.org/10.1016/j.siny.2021.101263

Findings demonstrate an association between impaired motor function and brain organisation in school-age children treated with therapeutic hypothermia for neonatal hypoxic-ischaemic #encephalopathy.

https://doi.org/10.1016/j.nicl.2021.102872